Furthermore, 43.33% (13/30) of the analyzed triple-negative breast tumors exhibited BRCA1 promoter hypermethylation (Figure 3a), strengthening the role of BRCA1 promoter hypermethylation in aggressive breast cancer subtypes. The gene discussed is BRCA1; the disease is breast carcinoma.